U.S. FDA adds abuse warning to prescription testosterone

Oct 25 (Reuters) - Drugs used to treat low testosterone will carry a new warning about the potential risk of abuse, the U.S. Food and Drug Administration said on Tuesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.